Page last updated: 2024-11-01

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Osteoarthritis, Knee

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Osteoarthritis, Knee in 1 studies

N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.

Osteoarthritis, Knee: Noninflammatory degenerative disease of the knee joint consisting of three large categories: conditions that block normal synchronous movement, conditions that produce abnormal pathways of motion, and conditions that cause stress concentration resulting in changes to articular cartilage. (Crenshaw, Campbell's Operative Orthopaedics, 8th ed, p2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
LeGrand, A1
Fermor, B1
Fink, C1
Pisetsky, DS1
Weinberg, JB1
Vail, TP1
Guilak, F1

Other Studies

1 other study available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Osteoarthritis, Knee

ArticleYear
Interleukin-1, tumor necrosis factor alpha, and interleukin-17 synergistically up-regulate nitric oxide and prostaglandin E2 production in explants of human osteoarthritic knee menisci.
    Arthritis and rheumatism, 2001, Volume: 44, Issue:9

    Topics: Aged; Amidines; Benzylamines; Cell Survival; Cells, Cultured; Cyclooxygenase Inhibitors; Cytokines;

2001